Critical Aspects of Initiation, Promotion, and Progression in Multistage Epidermal Carcinogenesis
暂无分享,去创建一个
S. Yuspa | T. Tennenbaum | D. Greenhalgh | D A Greenhalgh | S H Yuspa | T Tennenbaum | A. Glick | H. Hennings | H Hennings | A B Glick | D L Morgan | J E Strickland | J. Strickland | D. Morgan
[1] T. Slaga,et al. Simultaneous appearance of keratin modifications and gamma-glutamyltransferase activity as indicators of tumor progression in mouse skin papillomas. , 1983, Journal of the National Cancer Institute.
[2] R. Tarone,et al. Enhanced malignant conversion of benign mouse skin tumors by cisplatin. , 1990, Journal of the National Cancer Institute.
[3] I. Verma,et al. The fos oncogene. , 1987, Advances in cancer research.
[4] I. Berenblum,et al. The Persistence of Latent Tumour Cells Induced in the Mouse's Skin by a Single Application of 9:10-Dimethyl-1:2-Benzanthracene , 1949, British Journal of Cancer.
[5] E. Scolnick,et al. Altered growth and differentiation of cultured mouse epidermal cells infected with oncogenic retrovirus: contrasting effects of viruses and chemicals. , 1983, Cancer research.
[6] A. Balmain,et al. v-ras genes from harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis , 1986, Cell.
[7] S. Yuspa,et al. Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene , 1988, Molecular carcinogenesis.
[8] V. Potter. A new protocol and its rationale for the study of initiation and promotion of carcinogenesis in rat liver. , 1981, Carcinogenesis.
[9] M. Sporn,et al. Altered regulation of TGF-beta 1 and TGF-alpha in primary keratinocytes and papillomas expressing v-Ha-ras. , 1991, Molecular Carcinogenesis.
[10] S. Yuspa,et al. Malignant conversion and metastasis of mouse skin tumors: a comparison of SENCAR and CD-1 mice. , 1986, Environmental health perspectives.
[11] R. Tarone,et al. Malignant conversion of mouse skin tumours is increased by tumour initiators and unaffected by tumour promoters , 1983, Nature.
[12] S H Moolgavkar,et al. Mutation and cancer: a model for human carcinogenesis. , 1981, Journal of the National Cancer Institute.
[13] C. Conti,et al. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice. , 1987, Cancer research.
[14] H. T. Deelman. THE PART PLAYED BY INJURY AND REPAIR IN THE DEVELOPMENT OF CANCER , 1927, British medical journal.
[15] S. Yuspa. Cellular and molecular changes during chemical carcinogenesis in mouse skin cells. , 1985, Carcinogenesis; a comprehensive survey.
[16] T. Slaga,et al. Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[17] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[18] A. Steven,et al. Identification of a major keratinocyte cell envelope protein, loricrin , 1990, Cell.
[19] I. Berenblum,et al. The Mechanism of Carcinogenesis. A Study of the Significance of Cocarcinogenic Action and Related Phenomena , 1941 .
[20] S. Yuspa,et al. Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[21] T. Slaga,et al. Malignant progression of mouse skin papillomas treated with ethylnitrosourea, N-methyl-N'-nitro-N-nitrosoguanidine, or 12-O-tetradecanoylphorbol-13-acetate. , 1986, Cancer letters.
[22] J. Mottram. A developing factor in experimental blastogenesis , 1944 .
[23] V. Castronovo,et al. Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to appearance of early markers of tumor progression. , 1992, Cancer research.
[24] A. Balmain,et al. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[25] Robert A. Weinberg,et al. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes , 1983, Nature.
[26] J. Williamson,et al. Ionizing radiation enhances malignant progression of mouse skin tumors. , 1987, Carcinogenesis.
[27] H. Hennings,et al. Enhancement of skin tumorigenesis by a single application of croton oil before or soon after initiation by urethan. , 1973, Cancer research.
[28] Allan Balmain,et al. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas , 1984, Nature.
[29] P. Shubik. The growth potentialities of induced skin tumors in mice; the effects of different methods of chemical carcinogenesis. , 1950, Cancer research.
[30] D. Roop,et al. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. , 1988, Cancer research.
[31] T. Slaga,et al. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide. , 1986, Cancer research.
[32] H. Hennings,et al. Studies on the mechanism of skin tumor promotion. , 1970, Cancer research.
[33] P. Shubik,et al. A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin , 1947, British Journal of Cancer.
[34] S. Yuspa,et al. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells. , 1992, Cancer research.
[35] S. Yuspa,et al. Induction of papillomas with a high probability of conversion to malignancy. , 1985, Carcinogenesis.
[36] Potter Vr. Initiation and promotion in cancer formation: the importance of studies on intercellular communication. , 1980 .
[37] I. Verma,et al. Differential expression of cellular oncogenes during pre- and postnatal development of the mouse , 1982, Nature.
[38] E. Lane,et al. Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. , 1991, The Journal of investigative dermatology.
[39] R. Storer,et al. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene. , 1986, Cancer research.
[40] R. Roberts,et al. Activation of the cellular harvey ras gene in mouse skin tumors initiated with urethane , 1989, Molecular carcinogenesis.
[41] S. Yuspa,et al. Development of murine epidermal cell lines which contain an activated rasHa oncogene and form papillomas in skin grafts on athymic nude mouse hosts. , 1988, Cancer research.
[42] S. Yuspa,et al. Response of carcinogen-altered mouse epidermal cells to phorbol ester tumor promoters and calcium. , 1987, The Journal of investigative dermatology.
[43] S. Yuspa,et al. Sensitivity of subpopulations of mouse skin papillomas to malignant conversion by urethane or 4-nitroquinoline N-oxide. , 1990, Cancer research.
[44] L. Matrisian,et al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Lowy,et al. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue , 1986, Nature.
[46] D. Roop,et al. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis. , 1991, Environmental health perspectives.
[47] T. Slaga,et al. Mechanisms of inhibition of tumor progression. , 1993, Basic life sciences.